Call for Open Innovation Program “MOIRe” 2024
MOIRe is an annual open innovation research program for drug discovery initiated by Mochida Pharmaceutical Co., Ltd, a large Japanese pharmaceutical company. Application form and more detailed information available online.
EU-Japan Biotech & Pharma Partnering Conference is open for registration
In September and October this year, the EU-Japan Biotech & Pharma Partnering Conference will once again bring together biotech and pharma companies from Europe and Japan, both online and on-site in Osaka, Japan.
Innovative Therapies Days
CCI Région Bourgogne Franche-Comté is organizing a B2B matching event within the frame of the scientific congress Innovative Therapies Days.
Mochida Pharmaceutical’s open innovation programme
Since 2019, the company is managing its MOIRe (Mochida Open Innovation Research) programme and is now inviting researchers and research representatives affiliated with public research institutions, universities, etc. to submit proposals for collaborative research.
News from EU-Japan Business Round Table’s member NEC Japan establishes European subsidiaries to strengthen its work on AI drug development
NEC strengthens its European life science activities where AI technology, biomedical science and ICT combine to develop advanced therapies for patients across the globe. Central and Northern Europe’s vivid entrepreneurial and scientific environment, and the European clinical network and regulatory infrastructure, help drive developments in immunotherapies.
ITALIA Pavilion at CPHI JAPAN 2023 with 13 companies
The Trade Promotion Section of the Italian Embassy has organized a national pavilion at the 20th edition of CPHI JAPAN (19-21 April 2023) with 13 companies. The aim of the participation to the tradeshow was to promote the excellence of Made in Italy, to show the high level of development achieved by Italian production techniques, and to strengthen the presence of the Italian pharmaceutical industry in the Japanese market, increasing the business opportunities for the companies.
Proposal call for drug discovery research
Asahi Kasei Pharma has announced the new application period for their annual “Open Innovation” solicitation of proposals for drug discovery research.
Export to Japan 9: Technical Regulations - Quasi-Drugs
20-01-21 | 10:30 - 11:00 AM CETVarious EU products and services began to enjoy benefits from the EU-Japan Economic Partners

EU-Japan Centre's News

The EU-Japan Centre is currently calling for expert report proposals for a new periodic monitoring…
The EU-Japan Centre is currently calling for expert report proposals for its quarterly ‘Japanese…
The Minerva Policy Reports deliver comprehensive research on the dynamic political, economic, and…


01/08/2024 - 31/03/2025
  The organization of the Vulcanus Programme is pending reception of a grant by the EU-Japan Centre for Industrial Cooperation for the Japanese fiscal year 2024-2025: Please note that this call is…
07/10/2024 - 11/10/2024
Are you running a business that operates in the Pharma, Biotechnologies, or Life Sciences sectors? Would you like to present your technologies and products to potential partners and clients from…
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter